Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

H3K27ac ChIP-seq analysis of genetically engineered mouse models (GEMMs) of PDA with KRAS and TP53 mutations

ABSTRACT: We profile H3K27ac signals in WT, KC and KPC mice of pancreatic cancer

ORGANISM(S): Mus musculus

PROVIDER: GSE190901 | GEO | 2022/12/20

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

ATAC-seq analysis of genetically engineered mouse models (GEMMs) of PDA with KRAS and TP53 mutations

Project description:We profile chromatin accessibility signals in WT, KC and KPC mice of pancreatic cancer

2022-12-20 | GSE190900 | GEO

RNA-Seq of genetically engineered mouse models (GEMMs) of PDA with or without KRAS and/or TP53 mutations

Project description:We profile gene expression upon WT, KC and KPC mice of pancreatic cancer

2022-12-20 | GSE190903 | GEO

FOSL2 CUT-tag analysis of genetically engineered mouse models (GEMMs) of PDA with KRAS and TP53 mutations

Project description:We profile FOSL2 genome occupancy upon KPC mice of pancreatic cancer

2022-12-20 | GSE190912 | GEO

p53 inhibitor iASPP is an unexpected suppressor of KRAS and inflammation driven pancreatic cancer

Project description:To investigate the transcriptomic effects of iASPP deletion or p53 mutation in the KRASG12D background Pdx1-Cre was used to delete iASPP in oncogenic KRASG12D expressing (KC) background to generate KC;iASPPΔ8/Δ8 mice. KC and KC;iASPPΔ8/Δ8 mice were then crossed with mice containing a p53R172H allele (equivalent to human p53 hotspot mutation R175H) to generate KPC and KPC;iASPPΔ8/Δ8 cohorts. Primary cell cultures were then derived from pancreatic ductal adenocarcinoma tissue for RNA-seq.

2023-07-06 | GSE226595 | GEO

Expression data from genetically engineered mouse models (GEMMs)

2013-07-02 | GSE39557 | GEO

Expression data from genetically engineered mouse models (GEMMs)

Project description:3 Cell lines from Apc, p53 (AP) GEMMs were compared to 12 cell lines from Apc, Kras, p53 (AKP) GEMMs. Mouse 430 2.0 arrays were used to determine genomic expression differences between the two genotypes (AP and AKP). RNA was extracted from 3 AP and 10 AKP cell lines using the Qiagen RNEasy kit, and hybridized to individual Affymetrix mouse 430 2.0 chips as per manufacturer's instructions

2013-07-02 | E-GEOD-39557 | biostudies-arrayexpress

Single Cell RNA seq of Genetically Engineered Mouse Models of Pancreatic Adenocarcinoma

Project description:We report the scRNAseq profiles of three mouse models of pancreatic cancer: KIC, KPfC, KPC. Analyses demonstrate the existence of 2 molecular subtypes of cancer cells, 2 molecular subtypes of cancer associated fibroblasts, and 2 molecular subtypes of cancer associated macrophages.

2019-01-25 | GSE125588 | GEO

Phenotype screens of genetically engineered mouse models of pancreatic cancer identify a Tgfa-Ccl2-paxillin axis driving human-like perineural invasion

Project description:Solid cancers such as pancreatic cancer (PDAC) often exploit nerves for rapid spread. This neural invasion (NI) is an independent prognostic factor in PDAC and the main trigger for local recurrence and severe pain. However, genetically engineered mouse models (GEMM) of PDAC do not adequately represent the morphology of human NI. Therefore, we performed a systematic morphological screening of mutant mice with combinations of mutant alleles of oncogenes and tumour suppressors from our mouse repository. In a newly generated TPAC and TPC mouse mutant with pancreas-specific overexpression of transforming growth factor alpha (TGFa) and conditional deletion of p53, we identified human-like NI. To dissect the molecular mechanisms behind, we compared the transcriptome of TPAC and TPC mouse mutants with known KPC and KC mice lacking NI pathology. Our results revealed strong enrichment of genes encoding the extracellular matrix, including ECM glycoproteins, collagens and proteoglycans involved in biological oxidation, nuclear receptors, and proteins encoding drug metabolism via cytochrome P450 and retinoic acid signaling in TPAC cancer cells.

2022-05-05 | GSE201994 | GEO